These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 12552351)

  • 21. Searching for a neurobiological basis for self-medication theory in ADHD comorbid with substance use disorders: an in vivo study of dopamine transporters using (99m)Tc-TRODAT-1 SPECT.
    Silva N; Szobot CM; Shih MC; Hoexter MQ; Anselmi CE; Pechansky F; Bressan RA; Rohde LA
    Clin Nucl Med; 2014 Feb; 39(2):e129-34. PubMed ID: 23856832
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Availability of dopamine transporters and auditory P300 abnormalities in adults with attention-deficit hyperactivity disorder: preliminary results.
    Chu CL; Lee IH; Chi MH; Chen KC; Chen PS; Yao WJ; Chiu NT; Yang YK
    CNS Spectr; 2018 Aug; 23(4):264-270. PubMed ID: 28847342
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stimulant-like action of nicotine on striatal dopamine transporter in the brain of adults with attention deficit hyperactivity disorder.
    Krause KH; Dresel SH; Krause J; Kung HF; Tatsch K; Ackenheil M
    Int J Neuropsychopharmacol; 2002 Jun; 5(2):111-3. PubMed ID: 12135534
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SPECT and PET of the dopamine transporter in attention-deficit/hyperactivity disorder.
    Krause J
    Expert Rev Neurother; 2008 Apr; 8(4):611-25. PubMed ID: 18416663
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A second-generation 99m technetium single photon emission computed tomography agent that provides in vivo images of the dopamine transporter in primate brain.
    Meltzer PC; Blundell P; Zona T; Yang L; Huang H; Bonab AA; Livni E; Fischman A; Madras BK
    J Med Chem; 2003 Jul; 46(16):3483-96. PubMed ID: 12877586
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Availability of Striatal Dopamine Transporter in Healthy Individuals With and Without a Family History of ADHD.
    Tai YC; Chi MH; Chu CL; Chiu NT; Yao WJ; Chen PS; Yang YK
    J Atten Disord; 2019 May; 23(7):665-670. PubMed ID: 27401239
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular imaging genetics of methylphenidate response in ADHD and substance use comorbidity.
    Szobot CM; Roman T; Hutz MH; Genro JP; Shih MC; Hoexter MQ; Júnior N; Pechansky F; Bressan RA; Rohde LA
    Synapse; 2011 Feb; 65(2):154-9. PubMed ID: 20593420
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacological effects of dopaminergic drugs on in vivo binding of [99mTc]TRODAT-1 to the central dopamine transporters in rats.
    Dresel SH; Kung MP; Plössl K; Meegalla SK; Kung HF
    Eur J Nucl Med; 1998 Jan; 25(1):31-9. PubMed ID: 9396872
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dopamine transporter gene, response to methylphenidate and cerebral blood flow in attention-deficit/hyperactivity disorder: a pilot study.
    Rohde LA; Roman T; Szobot C; Cunha RD; Hutz MH; Biederman J
    Synapse; 2003 May; 48(2):87-9. PubMed ID: 12619042
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vivo neuroreceptor imaging in attention-deficit/hyperactivity disorder: a focus on the dopamine transporter.
    Spencer TJ; Biederman J; Madras BK; Faraone SV; Dougherty DD; Bonab AA; Fischman AJ
    Biol Psychiatry; 2005 Jun; 57(11):1293-300. PubMed ID: 15950001
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The dopamine transporter and neuroimaging in attention deficit hyperactivity disorder.
    Krause KH; Dresel SH; Krause J; la Fougere C; Ackenheil M
    Neurosci Biobehav Rev; 2003 Nov; 27(7):605-13. PubMed ID: 14624805
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical testing of an optimized software solution for an automated, observer-independent evaluation of dopamine transporter SPECT studies.
    Koch W; Radau PE; Hamann C; Tatsch K
    J Nucl Med; 2005 Jul; 46(7):1109-18. PubMed ID: 16000279
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Striatal dopamine transporter imaging correlates with anxiety and depression symptoms in Parkinson's disease.
    Weintraub D; Newberg AB; Cary MS; Siderowf AD; Moberg PJ; Kleiner-Fisman G; Duda JE; Stern MB; Mozley D; Katz IR
    J Nucl Med; 2005 Feb; 46(2):227-32. PubMed ID: 15695780
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The dopamine transporter and attention-deficit/hyperactivity disorder.
    Madras BK; Miller GM; Fischman AJ
    Biol Psychiatry; 2005 Jun; 57(11):1397-409. PubMed ID: 15950014
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of dopamine transporter imaging in routine clinical practice.
    Marshall V; Grosset D
    Mov Disord; 2003 Dec; 18(12):1415-23. PubMed ID: 14673877
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of dopamine transporter genotype and maternal prenatal smoking in childhood hyperactive-impulsive, inattentive, and oppositional behaviors.
    Kahn RS; Khoury J; Nichols WC; Lanphear BP
    J Pediatr; 2003 Jul; 143(1):104-10. PubMed ID: 12915833
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The optimal imaging time for [99Tcm]TRODAT-1/SPET in normal subjects and patients with Parkinson's disease.
    Kao PF; Tzen KY; Yen TC; Lu CS; Weng YH; Wey SP; Ting G
    Nucl Med Commun; 2001 Feb; 22(2):151-4. PubMed ID: 11258401
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Deep serotonergic and dopaminergic structures in fetal alcoholic syndrome: a study with nor-beta-CIT-single-photon emission computed tomography and magnetic resonance imaging volumetry.
    Riikonen RS; Nokelainen P; Valkonen K; Kolehmainen AI; Kumpulainen KI; Könönen M; Vanninen RL; Kuikka JT
    Biol Psychiatry; 2005 Jun; 57(12):1565-72. PubMed ID: 15953494
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dopamine transporter density measured by [123I]beta-CIT single-photon emission computed tomography is normal in dopa-responsive dystonia.
    Jeon BS; Jeong JM; Park SS; Kim JM; Chang YS; Song HC; Kim KM; Yoon KY; Lee MC; Lee SB
    Ann Neurol; 1998 Jun; 43(6):792-800. PubMed ID: 9629849
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is increased D2 receptor availability associated with response to stimulant medication in ADHD.
    Ilgin N; Senol S; Gucuyener K; Gokcora N; Sener S
    Dev Med Child Neurol; 2001 Nov; 43(11):755-60. PubMed ID: 11730150
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.